31 min listen
Why every clinical trial needs to consider Middle East and African sites: Interview with Ahmed Hamouda
Why every clinical trial needs to consider Middle East and African sites: Interview with Ahmed Hamouda
ratings:
Length:
26 minutes
Released:
Aug 25, 2021
Format:
Podcast episode
Description
Ahmed HamoudaAhmed Hamouda is the Head of Clinical Operations in the Middle East and Africa at RAY. In more than 10 years in the clinical research field, Ahmed has worked on both the CRO side and the pharmaceutical side in Europe, the Middle East, the Far East, and Africa. Ahmed brings the full range of his experience to bear at RAY, which provides outsourcing and consulting services to support pharmaceutical and biotech companies through the clinical trial development process. With RAY, Ahmed leverages his expertise to bring hope and opportunity to patient populations who would not otherwise be reached.Episode Highlights Why Africa and Middle Eastern markets represent a major opportunity for sponsorsWhat regulations and unique requirements sponsors need to understand before moving into these marketsHow the site selection and preparation process is different in these markets as opposed to in the U.S.The importance of partnering with qualified regional experts The challenges involved in driving patient participation in these regionsHow one rare disease clinical trial was saved by a move from the U.S. to the Middle East, and how that move paid off in terms of recruitmentPotential logistical issues with global trials and how RAY manages themWhy continuous education is so important for sitesHow Ahmed and RAY estimate the timeframe for study startup in a new regionThe unexpected positive regional outcomes of the pandemic Resources:Ray-CRO Ahmed Hamouda on LinkedInConversations in Clinical Trial Readiness Interview Series
Released:
Aug 25, 2021
Format:
Podcast episode
Titles in the series (12)
What We Learned from the Clin Ops Nightmares of 2020 with Kunal Sampat of Ceribell: In this episode, Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, speaks with Kunal Sampat of Ceribell, and discusses the changing landscape of clinical trial operations. An experienced Clinical Operations Director, Kunal shares his key learnings from 2020 and elaborates on some of the successes and challenges he’s seen this year. Industry stakeholders from CROs to site managers to sponsors will benefit from Kunal’s thoughtful advice and informed take on the current and future state of clinical operations. by Conversations in Clinical Trial Readiness